PROphet
®
PROphetNSCLC
TM
Test
PROphet
®
Technology
Resources
For Patients
For Providers
For Pharma
Science
Publications
Presentations
Clinical studies
Collaborators
About Us
News
In the news
Thought Leadership
Press releases
Meetings & Events
Awards
Contact Us
Careers
US openings
Israel openings
Order a test
PROphet
®
PROphetNSCLC
TM
Test
PROphet
®
Technology
Resources
For Patients
For Providers
For Pharma
Science
Publications
Presentations
Clinical Studies
Collaborators
News
In the News
Thought Leadership
Press Releases
Meetings & Events
Awards
Company
About us
Careers
Contact us
Order a test
In the News
Thought Leadership
Press Releases
Meetings & Events
Awards
January 19, 2021
OncoHost Raises $8 Million in Series B Funding Round
Original source
here.
Recent news
June 16, 2025
As AI Dawns in Precision Oncology, 2025 Expected To Be a ‘Turning Point’
Read more
June 6, 2025
OncoHost study offers insights into resistance mechanisms in immunotherapy-treated lung cancer
Read more
June 2, 2025
OncoHost study offers new insights into resistance mechanisms in immunotherapy-treated lung cancer patients
Read more
May 31, 2025
OncoHost Study Offers New Insights into Resistance Mechanisms in Immunotherapy-Treated Lung Cancer Patients
Read more
May 30, 2025
OncoHost Developing NeutroFlow Test for Guiding Cancer Therapy Selection
Read more
May 20, 2025
OncoHost receives a €2.5 million European grant to advance precision oncology
Read more
Read all news